Carleton Neil, Radomski Thomas R, Li Danyang, Zou Jian, Harris John, Hamm Megan, Wang Ziqi, Saadawi Gilan, Fischer Gary S, Arnold Jonathan, Cowher Michael S, Lupinacci Kristin, Sabih Quratulain, Steiman Jennifer, Johnson Ronald R, Soran Atilla, Diego Emilia J, Oesterreich Steffi, Tseng George, Lee Adrian V, McAuliffe Priscilla F
Women's Cancer Research Center, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.
Center for Research on Health Care, Division of General Internal Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
JAMA Surg. 2024 Oct 1;159(10):1117-1125. doi: 10.1001/jamasurg.2024.2407.
Choosing Wisely recommendations advocate against routine use of axillary staging in older women with early-stage, clinically node-negative (cN0), hormone receptor-positive (HR+), and HER2-negative breast cancer. However, rates of sentinel lymph node biopsy (SLNB) in this population remain persistently high.
To evaluate whether an electronic health record (EHR)-based nudge intervention targeting surgeons in their first outpatient visit with patients meeting Choosing Wisely criteria decreases rates of SLNB.
DESIGN, SETTING, AND PARTICIPANTS: This nonrandomized controlled trial was a hybrid type 1 effectiveness-implementation study with subsequent postintervention semistructured interviews and lasted from October 2021 to October 2023. Data came from EHRs at 8 outpatient clinics within an integrated health care system; participants included 7 breast surgical oncologists. Data were collected for female patients meeting Choosing Wisely criteria for omission of SLNB (aged ≥70 years with cT1 and cT2, cN0, HR+/HER2- breast cancer). The study included a 12-month preintervention control period; baseline surveys assessing perceived acceptability, appropriateness, and feasibility of the designed intervention; and a 12-month intervention period.
A column nudge was embedded into the surgeon's schedule in the EHR identifying patients meeting Choosing Wisely criteria for potential SLNB omission.
The primary outcome was rate of SLNB following nudge deployment into the EHR.
Similar baseline demographic and tumor characteristics were observed before (control period, n = 194) and after (intervention period, n = 193) nudge deployment. Patients in both the control and intervention period had a median (IQR) age of 75 (72-79) years. Compared with the control period, unadjusted rates of SLNB decreased by 23.1 percentage points (46.9% SLNB rate prenudge to 23.8% after; 95% CI, -32.9 to -13.8) in the intervention period. An interrupted time series model showed a reduction in the rate of SLNB following nudge deployment (adjusted odds ratio, 0.26; 95% CI, 0.07 to 0.90; P = .03). The participating surgeons scored the intervention highly on acceptability, appropriateness, and feasibility. Dominant themes from semistructured interviews indicated that the intervention helped remind the surgeons of potential Choosing Wisely applicability without the need for additional clicks or actions on the day of the patient visit, which facilitated use.
This study showed that a nudge intervention in the EHR significantly decreased low-value axillary surgery in older women with early-stage, cN0, HR+/HER2- breast cancer. This user-friendly and easily implementable EHR-based intervention could be a beneficial approach for decreasing low-value care in other practice settings or patient populations.
ClinicalTrials.gov Identifier: NCT06006910.
“明智选择”(Choosing Wisely)倡议主张,对于患有早期、临床淋巴结阴性(cN0)、激素受体阳性(HR+)且人表皮生长因子受体2阴性(HER2-)乳腺癌的老年女性,不建议常规进行腋窝分期检查。然而,该人群中前哨淋巴结活检(SLNB)的比例一直居高不下。
评估针对符合“明智选择”标准患者的外科医生首次门诊就诊时,基于电子健康记录(EHR)的助推干预措施是否能降低SLNB的比例。
设计、背景和参与者:这项非随机对照试验是一项混合型1类有效性-实施性研究,随后进行干预后半结构化访谈,研究从2021年10月持续至2023年10月。数据来自综合医疗系统内8家门诊诊所的电子健康记录;参与者包括7名乳腺外科肿瘤学家。收集符合“明智选择”标准可不进行SLNB的女性患者(年龄≥70岁,cT1和cT2,cN0,HR+/HER未2-乳腺癌)的数据。该研究包括一个为期12个月的干预前对照期;评估所设计干预措施的可接受性、适宜性和可行性的基线调查;以及一个为期12个月的干预期。
在电子健康记录中,在外科医生的日程安排中嵌入一个专栏助推提示,识别符合“明智选择”标准可能可不进行SLNB的患者。
主要结局是在电子健康记录中部署助推提示后SLNB的比例。
在部署助推提示之前(对照期,n = 194)和之后(干预期,n = 193),观察到相似的基线人口统计学和肿瘤特征。对照期和干预期的患者中位(IQR)年龄均为75(72 - 79)岁。与对照期相比,干预期SLNB的未调整比例下降了23.1个百分点(助推提示前SLNB比例为46.9%,之后为23.8%;95%CI,-32.9至-13.8)。中断时间序列模型显示,部署助推提示后SLNB比例降低(调整后的优势比,0.26;95%CI,0.07至0.90;P = 0.03)。参与研究的外科医生对该干预措施的可接受性、适宜性和可行性给予高度评价。半结构化访谈的主要主题表明,该干预措施有助于提醒外科医生“明智选择”标准的潜在适用性,而无需在患者就诊当天进行额外点击或操作,这便于使用。
本研究表明,电子健康记录中的助推干预措施显著减少了患有早期、cN0、HR+/HER2-乳腺癌的老年女性的低价值腋窝手术。这种用户友好且易于实施并基于电子健康记录的干预措施,可能是减少其他医疗环境或患者群体中低价值医疗的有益方法。
ClinicalTrials.gov标识符:NCT06006910。